The DOI matches its Crossref record; 237 of the 237 references it cites were found in a registry or an index.
Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
Open accessAbstract
The conventional paradigm of nonalcoholic fatty liver disease representing the "hepatic manifestation of the metabolic syndrome" is outdated. We identified and summarized longitudinal studies that, supporting the association of nonalcoholic fatty liver disease with either type 2 diabetes mellitus or metabolic syndrome, suggest that nonalcoholic fatty liver disease precedes the development of both conditions. Online Medical databases were searched, relevant articles were identified, their references were further assessed and tabulated data were checked. Although several cross-sectional studies linked nonalcoholic fatty liver disease to either diabetes and other components of the metabolic syndrome, we focused on 28 longitudinal studies which provided evidence for nonalcoholic fatty liver disease as a risk factor for the future development of diabetes. Moreover, additional 19 longitudinal reported that nonalcoholic fatty liver disease precedes and is a risk factor for the future development of the metabolic syndrome. Finally, molecular and genetic studies are discussed supporting the view that aetiology of steatosis and lipid intra-hepatocytic compartmentation are a major determinant of whether fatty liver is/is not associated with insulin resistance and metabolic syndrome. Data support the novel paradigm of nonalcoholic fatty liver disease as a strong determinant for the development of the metabolic syndrome, which has potentially relevant clinical implications for diagnosing, preventing and treating metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–237 of 237
Prospective association of 25( OH ) D with metabolic syndrome
Kayaniyil, S., Harris, S. B., Retnakaran, R. R., et al. (2013) · Clinical Endocrinology · doi:10.1111/cen.12190 · Cited by 50
Thyroid function and the metabolic syndrome in older persons: a population-based study
Heima, N. E., Eekhoff, E. M. W., Oosterwerff, M. M., Lips, P. T. A. M., van Schoor, N. M., & Şimşek, S. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0375 · Cited by 50
Rachas, A., Raffaitin, C., Barberger‐Gateau, P., Helmer, C., Ritchie, K. A., Tzourio, C., Amouyel, P., Ducimetière, P., & Empana, J. P. (2012) · Heart · doi:10.1136/heartjnl-2011-301185 · Cited by 47
Gut microbiota and non-alcoholic fatty liver disease
Paraskevas, Gkolfakis, George, Dimitriadis, Κωνσταντίνος, & Triantafyllou (2015) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 47
Caldwell, S. H., Ikura, Y., Iezzoni, J. C., & Liu, Z. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04639.x · Cited by 44
Alcohol Consumption and Incidence of Metabolic Syndrome in Korean Men
Kim, B. J., Kim, B. S., & Kang, J. H. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0315 · Cited by 44
Prospective study of alcohol consumption and the incidence of the metabolic syndrome in US men
Stoutenberg, M., Lee, D.-C., Sui, X., Hooker, S. P., Horigian, V. E., Perrino, T., & Blair, S. N. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114512005764 · Cited by 40
Barrio-López, M. T., Bes‐Rastrollo, M., Sayón-Orea, C., García–López, M., Fernández‐Montero, A., Gea, A., & Martínez‐González, M. Á. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.12.002 · Cited by 39
Elevation of liver enzymes within the normal limits and metabolic syndrome
Xia, M., Yan, H., Lin, H., Bian, H., Pan, B., Yao, X., Li, R.-K., Zeng, M., & Gao, X. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05519.x · Cited by 36
Kawamoto, R., Kohara, K., Tabara, Y., Miki, T., & Otsuka, N. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.no414 · Cited by 34
Treatment of NASH with ursodeoxycholic acid: Pro
Ratziu, V. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/s2210-7401(12)70020-7 · Cited by 34
Kim, J., Tanabe, K., Yoshizawa, Y., Yokoyama, N., Suga, Y., & Kuno, S. (2012) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.229.11 · Cited by 34
Zhang, Z., Bian, L., & Choi, Y. (2011) · Angiology · doi:10.1177/0003319711423806 · Cited by 34
Chen, C., Lin, W., Li, C.-I., Liu, C.-S., Li, T., Chen, Y.-T., Yang, C., Chang, M.-P., & Lin, C. (2012) · Nutrition Research · doi:10.1016/j.nutres.2011.11.004 · Cited by 33
Non‐Alcoholic Fatty Liver and Non‐Alcoholic Steatohepatitis
Farrell, G. C. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch13 · Cited by 31
Lee, K.-W., Park, B., Kang, H., & Lee, Y. (2011) · Alcohol · doi:10.1016/j.alcohol.2011.01.001 · Cited by 31
Management of fatty liver disease with the metabolic syndrome
Machado, M. V., & Cortez‐Pinto, H. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.903798 · Cited by 31
Coffee and the liver: a potential treatment for liver disease?
Masterton, G., & Hayes, P. C. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32833cca96 · Cited by 29
Association between Uric Acid and Metabolic Syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran
Ziaee, A., Esmailzadehha, N., Ghorbani, A., et al. (2012) · Global Journal of Health Science · doi:10.5539/gjhs.v5n1p155 · Cited by 29
Clinical physiology of NAFLD: a critical overview of pathogenesis and treatment
Lonardo, A., Caldwell, S. H., & Loria, P. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.5 · Cited by 25
Self-citationLi, X., Xia, M., Ma, H., Hu, Y., Yan, H., He, W., Lin, H., Zhao, N., Gao, J., & Gao, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065210 · Cited by 25
Prevalence of nonalcoholic fatty liver disease in subjects with metabolic syndrome.
Castro-Martínez, M. G., Banderas-Lares, D. Z., Ramírez-Martínez, J. C., & la Peña, J. E.-D. (2012) · PubMed · Cited by 24
Fatty Liver Increases the Association of Metabolic Syndrome With Diabetes and Atherosclerosis
Juárez-Rojas, J. G., Medina-Urrutia, A. X., Galarza, E. J., González-Salazar, C., Kimura‐Hayama, E., Cardoso-Saldaña, G. C., Posadas‐Sánchez, R., Martínez-Alvarado, M. R., & Posadas‐Romero, C. (2012) · Diabetes Care · doi:10.2337/dc12-1276 · Cited by 23
Ikai, E., Noborizaka, Y., Tsuritani, I., Honda, R., Ishizaki, M., & Yamada, Y. (1993) · Obesity Research · doi:10.1002/j.1550-8528.1993.tb00029.x · Cited by 21
Matsen, M. E., Thaler, J. P., Wisse, B. E., Guyenet, S. J., Meek, T. H., Ogimoto, K., Cubelo, A., Fischer, J. D., Kaiyala, K. J., Schwartz, M. W., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00488.2012 · Cited by 21
Boursier, J., Chaigneau, J., Roullier, V., Lainé, F., Sandrini, J., Michalak, S., Hubert, I., Dib, N., Oberti, F., Bertrais, S., et al. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32834a4d82 · Cited by 21
Lonardo, A., Sookoian, S. C., Chonchol, M., Loria, P., & Targher, G. (2012) · Current Pharmaceutical Design · doi:10.2174/13816128130301 · Cited by 21
Self-citationCarrieri, P., Sogni, P., Cohen, J., Loko, M., Winnock, M., & Spire, B. (2012) · Hepatology · doi:10.1002/hep.25813 · Cited by 19
Hagnäs, M. P., Cederberg, H., Mikkola, I., Ikäheimo, T. M., Jokelainen, J. J., Laakso, M., Härkönen, P. K., Peitso, A., Rajala, U., & Keinanen-Kiukaanniemi, S. M. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.009 · Cited by 19
Tao, L., Li, X., Zhu, H., Gao, Y., Luo, Y., Wang, W., Wang, Z., Chen, D., Wu, L., & Guo, X. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10115523 · Cited by 16
Yousefzadeh, G., Shokoohi, M., Yeganeh‐Hajahmadi, M., & Najafipour, H. (2012) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.08.013 · Cited by 15
Eraslan, S., Kızılgül, M., Uzunlulu, M., et al. (2013) · PubMed · Cited by 13
Treatment of NASH with ursodeoxycholic acid: Cons
Liechti, F., & Dufour, J. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/s2210-7401(12)70021-9 · Cited by 13
Metabolic Syndrome and Daily Ambulation in Children, Adolescents, and Young Adults
Gardner, A. W., Parker, D. E., Krishnan, S., & Chalmers, L. J. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3182699239 · Cited by 13
Predictors of the Development of Metabolic Syndrome in Male Workers: A 3-year Follow-Up Study
Kawada, T. (2012) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e3182492070 · Cited by 10
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia?
Ballestri, S., Lonardo, A., Losi, L., Pellegrini, E., Bertolotti, M., & Loria, P. (2008) · Internal and Emergency Medicine · doi:10.1007/s11739-008-0178-3 · Cited by 9
Self-citationKim, S.-H., Lee, J., & Hwang, H. (2011) · PubMed · Cited by 9
Cited by
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Aron-Wisnewsky, J., Vigliotti, C., Witjes, J., Le, P., Holleboom, A. G., Verheij, J., Nieuwdorp, M., & Clément, K. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0269-9 · Cited by 1,063
Tilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.147 · Cited by 1,002
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Younossi, Z. M., Otgonsuren, M., Henry, L., Venkatesan, C., Mishra, A., Erario, M., & Hunt, S. (2015) · Hepatology · doi:10.1002/hep.28123 · Cited by 802
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Lonardo, A., Nascimbeni, F., Mantovani, A., & Targher, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.021 · Cited by 736
Self-citation
Metadata
- Authors
- Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., & Loria, P.
- Venue
- Digestive and Liver Disease
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 47
- Issue
- 3
- Pages
- 181-190
- ISSN
- 1590-8658 (ISSN-L)
- OpenAlex
- W2068041970
- Cited by
- 685
- References
- 237
- FWCI
- 39.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.